Skip to main content

Research

The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.

People with type 1 and 2 diabetes report experiencing diabetes stigma regardless of which devices they use. But when we start looking at which groups report the most...
end Uncover SURMOUNT-2 trial's outcomes: Tirzepatide's promise for weight loss, better blood sugar, and improved cardiometabolic health in type 2 diabetes.
New drug treatments are now available for children with diabetes following the recent approval of Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin...
Join diaTribe at the American Diabetes Association's 83rd scientific conference for insights on future diabetes care, medication, and the latest tech. Plus, explore...
Early screening for type 1 diabetes is vital for timely treatment and prevention of certain complications. With recent advancements such as the FDA approval of Tzield (...
Explore groundbreaking research that connects type 2 diabetes and Alzheimer's disease through mitochondrial dysfunction. The link unveils new insights in elder care and...
New findings from the DiRECT trial reveal that weight loss can lead to type 2 diabetes remission. Learn about the benefits of a low-calorie diet and support in diabetes...
Reduce heart failure risk with FDA-approved Inpefa (sotagliflozin). Inhibiting SGLT-2 and SGLT-1, it outshines other medications. Learn more about its effectiveness and...
In case you missed them, here are our top stories from May 2023. This month’s best stories cover a wide variety of topics like upcoming therapies, new research findings...
Oculis' OCS-01 eye drops show promising results in phase 3 trials for diabetic macular edema treatment. Uncover a potential revolution in non-invasive eye care solutions.
Non-invasive glucose monitoring technology has been a dream of people with diabetes for years. Get the latest update on the research and development of these devices.
The National Institute of Clinical Excellence recently announced it was the first to expand access to automated glucose monitors for children with type 2 diabetes. The...
Farxiga (dapagliflozin), a SGLT-2 inhibitor, has officially been approved by the FDA to treat all types of heart failure, a common diabetes complication.
Learn how to increase access to diabetes tech for children with type 1 diabetes. Healthcare providers discuss how treatments and better access to resources can help...
In a recent study, results showed that improved access to CGM can lower A1C levels in Hispanic children. However, broader societal strategies are needed to address...
Early-stage study results show that a new one-hour intestinal procedure called ReCET may be able to help people with type 2 diabetes improve their blood sugars enough to...
Researchers released early clinical trial results on an innovative cell treatment for people with type 2 diabetes. After one year, 93% of those who received the...
The FDA recently cleared a new experimental drug for type 1 diabetes to begin a phase 2 clinical trial. If approved, the drug would be the first therapy to specifically...
Researchers released clinical trial data on a new treatment for type 2 diabetes that may help the body’s insulin-producing cells regenerate. 78% of the clinical trial’s...
According to a recent study, children who develop type 1 diabetes may have signs in their gut as early as age 1. Researchers have found differences in gut bacteria that...

Pages